University of Minnesota’s World-Renowned Fanconi Anemia Treatment and Research Program Renamed

Published by
Published by: 
Krystle Barbour, Media and Public Relations Specialist
July 11, 2018

   

University of Minnesota Masonic Children's Hospital is the largest treatment center in the United States for patients with the rare genetic disease Fanconi anemia (FA). In recognition of Kidz1stFund, which has donated more than $5.5 million for FA research at Masonic Children’s, the University of Minnesota’s treatment and research program for FA will become the Kidz1stFund Comprehensive Fanconi Anemia Center.

Jimbo Fisher and Candi Fisher founded Kidz1stFund in 2011, when their youngest son was diagnosed with Fanconi anemia, a rare, genetic disease that leads to bone marrow failure and other conditions. It affects about one in every 131,000 births each year.

Read the news release for more information about how Kidz1stFund and the U of M are working together to improve the success of blood and marrow transplants for people with FA.

Share this post

You may also like:

A first of its kind discovery could mean new understandings in non-alcoholic fatty liver disease.

The VA Longitudinal Undergraduate Medical Education clerkship, often referred to as VALUE, places a tremendous effort in creating the best experience for students– and patients.

Endowment from Lupus Link Minnesota helps Center for Autoimmune Diseases Research to focus on systemic lupus.